205 related articles for article (PubMed ID: 35040787)
1. Correlation Between Proton Pump Inhibitors and the Complications of Liver Cirrhosis: A Systematic Review and Meta-Analysis.
Hwang SJ; Lee DH; Koh SJ; Kim JW; Park HS; Kim BG; Lee KL
Turk J Gastroenterol; 2022 Jan; 33(1):44-52. PubMed ID: 35040787
[TBL] [Abstract][Full Text] [Related]
2. Proton pump inhibitor use and risk of spontaneous bacterial peritonitis in cirrhotic patients: a systematic review and meta-analysis.
Xu HB; Wang HD; Li CH; Ye S; Dong MS; Xia QJ; Zhang AQ; Pan K; Ge XL; Dong JH
Genet Mol Res; 2015 Jul; 14(3):7490-501. PubMed ID: 26214428
[TBL] [Abstract][Full Text] [Related]
3. Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites.
Dam G; Vilstrup H; Watson H; Jepsen P
Hepatology; 2016 Oct; 64(4):1265-72. PubMed ID: 27474889
[TBL] [Abstract][Full Text] [Related]
4. Proton pump inhibitor intake neither predisposes to spontaneous bacterial peritonitis or other infections nor increases mortality in patients with cirrhosis and ascites.
Mandorfer M; Bota S; Schwabl P; Bucsics T; Pfisterer N; Summereder C; Hagmann M; Blacky A; Ferlitsch A; Sieghart W; Trauner M; Peck-Radosavljevic M; Reiberger T
PLoS One; 2014; 9(11):e110503. PubMed ID: 25369194
[TBL] [Abstract][Full Text] [Related]
5. Proton pump inhibitor use significantly increases the risk of spontaneous bacterial peritonitis in 1965 patients with cirrhosis and ascites: a propensity score matched cohort study.
Min YW; Lim KS; Min BH; Gwak GY; Paik YH; Choi MS; Lee JH; Kim JJ; Koh KC; Paik SW; Yoo BC; Rhee PL
Aliment Pharmacol Ther; 2014 Sep; 40(6):695-704. PubMed ID: 25078671
[TBL] [Abstract][Full Text] [Related]
6. Role of proton pump inhibitors in the occurrence and the prognosis of spontaneous bacterial peritonitis in cirrhotic patients with ascites.
de Vos M; De Vroey B; Garcia BG; Roy C; Kidd F; Henrion J; Deltenre P
Liver Int; 2013 Oct; 33(9):1316-23. PubMed ID: 23730823
[TBL] [Abstract][Full Text] [Related]
7. Proton Pump Inhibitors Increases Longitudinal Risk of Mortality, Decompensation, and Infection in Cirrhosis: A Meta-Analysis.
Wong ZY; Koh JH; Muthiah M; Koh B; Ong EYH; Ong CEY; Ou KQ; Lim WH; Tan DJH; Chee D; Siah KTH; Wong Y; Kaewdech A; Wijarnpreecha K; Kulkarni AV; Nah B; Huang DQ; Noureddin M; Ng CH; Teng M
Dig Dis Sci; 2024 Jan; 69(1):289-297. PubMed ID: 37968557
[TBL] [Abstract][Full Text] [Related]
8. Association of proton pump inhibitors with risk of hepatic encephalopathy in advanced liver disease: A meta-analysis.
Tantai XX; Yang LB; Wei ZC; Xiao CL; Chen LR; Wang JH; Liu N
World J Gastroenterol; 2019 Jun; 25(21):2683-2698. PubMed ID: 31210719
[TBL] [Abstract][Full Text] [Related]
9. Dose-dependent impact of proton pump inhibitors on the clinical course of spontaneous bacterial peritonitis.
Tergast TL; Wranke A; Laser H; Gerbel S; Manns MP; Cornberg M; Maasoumy B
Liver Int; 2018 Sep; 38(9):1602-1613. PubMed ID: 29675988
[TBL] [Abstract][Full Text] [Related]
10. Proton pump inhibitors use and risk of developing spontaneous bacterial peritonitis in cirrhotic patients: A systematic review and meta-analysis.
Alhumaid S; Al Mutair A; Al Alawi Z; Zaidi ARZ; Rabaan AA; Elhazmi A; Al-Omari A
Gut Pathog; 2021 Mar; 13(1):17. PubMed ID: 33741033
[TBL] [Abstract][Full Text] [Related]
11. Proton Pump Inhibitor Therapy and Hepatic Encephalopathy Risk in Cirrhotic Patients: A Systematic Review with Meta-analysis.
Shi D; Zhou Z; Dai Y; Pan X; Cao Q
Clin Drug Investig; 2019 Sep; 39(9):847-856. PubMed ID: 31183628
[TBL] [Abstract][Full Text] [Related]
12. Proton pump inhibitor use is associated with spontaneous bacterial peritonitis in patients with liver cirrhosis.
Miura K; Tanaka A; Yamamoto T; Adachi M; Takikawa H
Intern Med; 2014; 53(10):1037-42. PubMed ID: 24827481
[TBL] [Abstract][Full Text] [Related]
13. Proton pump inhibitor use increases mortality and hepatic decompensation in liver cirrhosis.
De Roza MA; Kai L; Kam JW; Chan YH; Kwek A; Ang TL; Hsiang JC
World J Gastroenterol; 2019 Sep; 25(33):4933-4944. PubMed ID: 31543684
[TBL] [Abstract][Full Text] [Related]
14. Proton pump inhibitor therapy and its association with spontaneous bacterial peritonitis incidence and mortality: A meta-analysis.
Yu T; Tang Y; Jiang L; Zheng Y; Xiong W; Lin L
Dig Liver Dis; 2016 Apr; 48(4):353-9. PubMed ID: 26795544
[TBL] [Abstract][Full Text] [Related]
15. Proton pump inhibitor use and association with spontaneous bacterial peritonitis in patients with cirrhosis and ascites.
Siple JF; Morey JM; Gutman TE; Weinberg KL; Collins PD
Ann Pharmacother; 2012 Oct; 46(10):1413-8. PubMed ID: 23032651
[TBL] [Abstract][Full Text] [Related]
16. Association Between Proton Pump Inhibitor Therapy and Spontaneous Bacterial Peritonitis Occurrence in Cirrhotic Patients: A Clinical Review.
Zhang M; Liu W; Xu X; Chen T; Qi JY
Curr Med Sci; 2022 Aug; 42(4):673-680. PubMed ID: 35870102
[TBL] [Abstract][Full Text] [Related]
17. Association between proton pump inhibitor use and spontaneous bacterial peritonitis in cirrhotic patients with ascites.
Ratelle M; Perreault S; Villeneuve JP; Tremblay L
Can J Gastroenterol Hepatol; 2014 Jun; 28(6):330-4. PubMed ID: 24945188
[TBL] [Abstract][Full Text] [Related]
18. Proton Pump Inhibitors Use and Increased Risk of Spontaneous Bacterial Peritonitis in Cirrhotic Patients: A Retrospective Cohort Analysis.
Dahabra L; Kreidieh M; Abureesh M; Abou Yassine A; Deeb L
Gastroenterology Res; 2022 Aug; 15(4):180-187. PubMed ID: 36128183
[TBL] [Abstract][Full Text] [Related]
19. Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites.
Bajaj JS; Zadvornova Y; Heuman DM; Hafeezullah M; Hoffmann RG; Sanyal AJ; Saeian K
Am J Gastroenterol; 2009 May; 104(5):1130-4. PubMed ID: 19337238
[TBL] [Abstract][Full Text] [Related]
20. Association between proton pump inhibitors and spontaneous bacterial peritonitis in cirrhotic patients - a systematic review and meta-analysis.
Trikudanathan G; Israel J; Cappa J; O'Sullivan DM
Int J Clin Pract; 2011 Jun; 65(6):674-8. PubMed ID: 21564440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]